Chronic spinal cord electrical stimulation protects against 6-hydroxydopamine lesions

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Yadav, Amol P ^a   Fuentes, Romulo ^b   Zhang, Hao ^c   Vinholo, Thais ^c   Wang, Chi Han ^c   Freire, Marco Aurelio M ^b   Nicolelis, Miguel A L ^a,b,c,d  

^a Duke University   (United States)

^b Edmond and Lily Safra International Institute of Neuroscience of Natal   (Brazil)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; NEUROPROTECTIVE AGENT; OXIDOPAMINE;

ANIMAL; ANIMAL BEHAVIOR; BRAIN DEPTH STIMULATION; CHEMICALLY INDUCED; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECTS; LONG EVANS RAT; MALE; MOTOR ACTIVITY; PATHOLOGY; PROCEDURES; RADIATION RESPONSE; RAT; SPINAL CORD DISEASES; SPINAL CORD STIMULATION;

ADRENERGIC AGENTS; ANIMALS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; DEEP BRAIN STIMULATION; DISEASE MODELS, ANIMAL; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; RATS; RATS, LONG-EVANS; SPINAL CORD DISEASES; SPINAL CORD STIMULATION;

EID: 84898877880     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03839     Document Type: Article

References (43)

1. Carlsson, A. Biochemical and pharmacological aspects of Parkinsonism. Acta Neurol. Scand. Suppl. 51, 11-42 (1972).
2. Nagatsua, T. & Sawadab, M. L-dopa therapy for Parkinson's disease: past, present, and future. Parkinsonism Relat Disord 15 Suppl 1, S3-8, doi:10.1016/S1353-8020(09)70004-5 (2009).
3. Benabid, A. L. Deep brain stimulation for Parkinson's disease. Curr. Opin. Neurobiol. 13, 696-706 (2003).
4. Morgante, L. et al. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord 13, 528-531, doi:10.1016/j.parkreldis. 2006.12.013 (2007). (Pubitemid 350110555)
5. Fuentes, R., Petersson, P., Siesser, W. B., Caron, M. G. & Nicolelis, M. A. Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science 323, 1578-1582, doi:10.1126/science.1164901 (2009).
6. Thevathasan, W. et al . Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease. Neurology 74, 1325-1327, doi:10.1212/WNL.0b013e3181d9ed58 (2010).
7. Nicolelis, M. A., Fuentes, R., Petersson, P., Thevathasan, W. & Brown, P. Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease. Neurology 75, 1484; author reply 1484-1485, doi:10.1212/WNL.0b013e3181f46f10 (2010).
8. Fenelon, G. et al. Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson's disease. Parkinsonism Relat Disord 18, 213-214, doi:10.1016/j.parkreldis.2011.07.015 (2012).
9. Agari, T. & Date, I. Spinal cord stimulation for the treatment of abnormal posture and gait disorder in patients with Parkinson's disease. Neurol. Med. Chir. (Tokyo). 52, 470-474 (2012).
10. Landi, A. et al. Spinal Cord Stimulation for the Treatment of Sensory Symptoms in Advanced Parkinson's Disease. Neuromodulation: journal of the International Neuromodulation Society, doi:10.1111/ner.12005 (2012).
11. Hassan, S., Amer, S., Alwaki, A. & Elborno, A. A patient with Parkinson's disease benefits from spinal cord stimulation. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia, doi:10.1016/j.jocn.2012.08.018 (2013).
12. Aguilar, J. et al. Spinal direct current stimulation modulates the activity of gracile nucleus and primary somatosensory cortex in anaesthetized rats. The Journal of physiology 589, 4981-4996, doi:10.1113/jphysiol.2011.214189 (2011).
13. Stancak, A. et al. Functional magnetic resonance imaging of cerebral activation during spinal cord stimulation in failed back surgery syndrome patients. Eur J Pain 12, 137-148, doi:10.1016/j.ejpain.2007.03.003 (2008). (Pubitemid 350180534)
14. Dejongste, M. J., Hautvast, R. W., Ruiters, M. H. & Ter Horst, G. J. Spinal Cord Stimulation and the Induction of c-fos and Heat Shock Protein 72 in the Central Nervous System of Rats. Neuromodulation: journal of the International Neuromodulation Society 1, 73-84, doi:10.1111/j.1525-1403.1998. tb00020.x (1998).
15. Maeda, Y., Ikeuchi, M., Wacnik, P. & Sluka, K. A. Increased c-fos immunoreactivity in the spinal cord and brain following spinal cord stimulation is frequency-dependent. Brain Res. 1259, 40-50, doi:10.1016/j.brainres.2008.12. 060 (2009).
16. Lenard, L. et al. Feeding and body weight regulation after 6-OHDA application into the preoptic area. Brain Res. Bull. 27, 359-365 (1991).
17. Ferro, M. M. et al.Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations. J. Neurosci. Methods 148, 78-87, doi:10.1016/j.jneumeth.2005.04.005 (2005). (Pubitemid 41423461)
18. Roedter, A. et al. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. J. Comp. Neurol. 432, 217-229 (2001).
19. Muller, J. et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch. Neurol. 58, 259-264 (2001).
20. Ondo, W. G. et al. Weight gain following unilateral pallidotomy in Parkinson's disease. Acta Neurol. Scand. 101, 79-84 (2000).
21. Bachmann, C. G. & Trenkwalder, C. Body weight in patients with Parkinson's disease. Mov. Disord. 21, 1824-1830, doi:10.1002/mds.21068 (2006). (Pubitemid 44848926)
22. Moro, E. et al. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 53, 85-90 (1999).
23. Macia, F. et al. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov. Disord. 19, 206-212, doi:10.1002/mds.10630 (2004). (Pubitemid 38312705)
24. Gironell, A., Pascual-Sedano, B., Otermin, P. & Kulisevsky, J. [Weight gain after functional surgery for Parkinsons disease]. Neurologia 17, 310-316 (2002).
25. Pirke, K. M., Broocks, A., Wilckens, T., Marquard, R. & Schweiger, U. Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes. Neurosci. Biobehav. Rev. 17, 287-294 (1993).
26. Holsheimer, J. Which Neuronal Elements are Activated Directly by Spinal Cord Stimulation. Neuromodulation: journal of the International Neuromodulation Society 5, 25-31, doi:10.1046/j.1525-1403.2002.-2005.x (2002).
27. Dimitrijevic, M. R., Faganel, J., Sharkey, P. C. & Sherwood, A. M. Study of sensation and muscle twitch responses to spinal cord stimulation. Int. Rehabil. Med. 2, 76-81 (1980).
28. Nashold, B. S. Jr., Somjen, G. & Friedman, H. The effects of stimulating the dorsal columns of man. Med. Prog. Technol. 1, 89-91 (1972).
29. Kaas, J. H. et al. Cortical and subcortical plasticity in the brains of humans, primates, and rats after damage to sensory afferents in the dorsal columns of the spinal cord. Exp. Neurol. 209, 407-416, doi:10.1016/j.expneurol. 2007.06.014 (2008). (Pubitemid 351174131)
30. Kish, S. J., Shannak, K. & Hornykiewicz, O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 318, 876-880, doi:10.1056/NEJM198804073181402 (1988). (Pubitemid 18090271)
31. Shults, C. W., Kimber, T. &Altar, C. A. BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine. Neuroreport 6, 1109-1112 (1995).
32. Klein, R. L., Lewis, M. H., Muzyczka, N. & Meyer, E. M. Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer. Brain Res. 847, 314-320 (1999).
33. Spieles-Engemann, A. L., Collier, T. J.&Sortwell, C. E. A functionally relevant and long-term model of deep brain stimulation of the rat subthalamic nucleus: advantages and considerations. Eur. J. Neurosci. 32, 1092-1099, doi:10.1111/j.1460-9568.2010.07416.x (2010).
34. Spieles-Engemann, A. L. et al. Subthalamic Nucleus Stimulation Increases Brain Derived Neurotrophic Factor in the Nigrostriatal System and Primary Motor Cortex. J Parkinsons Dis 1, 123-136 (2011).
35. Hilker, R. et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psychiatry 76, 1217-1221, doi:10.1136/jnnp.2004.057893 (2005). (Pubitemid 41208371)
36. Fuentes, R., Petersson, P. & Nicolelis, M. A. Restoration of locomotive function in Parkinson's disease by spinal cord stimulation: mechanistic approach. Eur. J. Neurosci. 32, 1100-1108, doi:10.1111/j.1460-9568. 2010.07417.x (2010).
37. Winkler, C., Kirik, D., Bjorklund, A. & Cenci, M. A. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 10, 165-186 (2002).
38. Hrdina, P. D. & Dubas, T. C. Brain distribution and kinetics of desipramine in the rat. Can. J. Physiol. Pharmacol. 59, 163-167 (1981).
39. Deumens, R., Blokland, A.& Prickaerts, J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 175, 303-317, doi:10.1006/exnr.2002.7891 (2002). (Pubitemid 34634286)
40. Paxinos, G. & Watson, C. The rat brain, in stereotaxic coordinates. Compact 3rd edn, (Academic Press, 1997).
41. Tischler, A. S. Triple immunohistochemical staining for bromodeoxyuridine and catecholamine biosynthetic enzymes using microwave antigen retrieval. J. Histochem. Cytochem. 43, 1-4 (1995).
42. Freire, M. A., Oliveira, R. B., Picanco-Diniz, C. W. & Pereira, A. Jr. Differential effects of methylmercury intoxication in the rat's barrel field as evidenced by NADPH diaphorase histochemistry. Neurotoxicology 28, 175-181, doi:10.1016/j.neuro.2006.06.007 (2007). (Pubitemid 46187255)
43. Abercrombie, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94, 239-247 (1946).